Receptor activator of nuclear factor κB ligand is expressed in resident and inflammatory cells in aseptic and septic prosthesis loosening

被引:42
作者
Gehrke, T
Sers, C
Morawietz, L
Fernahl, G
Neidel, J
Frommelt, L
Krenn, V
机构
[1] ENDO Klin Hamburg, Hamburg, Germany
[2] Univ Clin Charite, Inst Pathol, Berlin, Germany
[3] Univ Clin Charite, Dept Orthopaed, Berlin, Germany
关键词
RANKL; RANK; OPG; septic loosening; aseptic loosening; endoprosthesis; DEBRIS-INDUCED OSTEOLYSIS; RHEUMATOID-ARTHRITIS; OSTEOCLAST DIFFERENTIATION; OSTEOPROTEGERIN LIGAND; GENE-THERAPY; TOTAL HIP; T-CELLS; REPLACEMENTS; MACROPHAGES; CYTOKINE;
D O I
10.1080/03009740310003929
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The pathogenesis of periprosthetic bone loss in aseptic and septic prosthesis loosening is unclear. There is considerable evidence that macrophages and osteoclasts play a key role in focal bone erosion and osteolysis around the prosthesis. RANKL (receptor activator of nuclear factor kappaB ligand) was shown to be a potent osteoclastogenic factor, and to be involved in bone destruction of myeloma and rheumatoid arthritis patients. Osteoprotegerin (OPG) is the natural RANKL inhibitor and may prevent periprosthetic bone loss. Methods: The presence and distribution of RANKL, its receptor RANK and OPG in the periprosthetic interface of septically (n=5) and aseptically (n=6) loosened prostheses was examined by immunohistochemistry and immunoblotting. Additionally, the immunophenotype of the inflammatory infiltrate was determined [CD3, CD68, Ki-67, tartrate-resistant acid posphatase (TRAP)]. Results: Aseptic and septic cases revealed a different histopathologic pattern. However, in all cases RANKL and RANK could be demonstrated in macrophages and giant cells. In addition, RANKL detected by immunoblot analysis proved to have the same molecular weight as a recombinant RANKL used as a control (31 kappaD and approximately 48 kappaD). OPG was detected in aseptic loosening, where macrophages showed a strong staining, but multinucleated giant cells were only weakly stained. A weak OPG staining was also observed in septic loosening. Conclusion: The pathogenesis of bone loss in septic loosening remains unclear, because the septic membrane bears few macrophages and giant cells, and half of them express OPG. In aseptic loosening, macrophages might not be stimulated by RANKL as a result of OPG expression. But multinucleated giant cells may be activated, as they hardly express OPG. They might be responsible for periprosthetic bone loss in aseptic loosening as a result of their RANKL and RANK expression.
引用
收藏
页码:287 / 294
页数:8
相关论文
共 32 条
[1]   Osteoprotegerin and its ligand: A new paradigm for regulation of osteoclastogenesis and bone resorption [J].
Aubin, JE ;
Bonnelye, E .
OSTEOPOROSIS INTERNATIONAL, 2000, 11 (11) :905-913
[2]   Twenty-five-year survivorship of two thousand consecutive primary Charnley total hip replacements - Factors affecting survivorship of acetabular and femoral components [J].
Berry, DJ ;
Harmsen, WS ;
Cabanela, ME ;
Morrey, BF .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 2002, 84A (02) :171-177
[3]  
CHARNLEY J, 1979, LOW FRICTION ARTHROP, P52
[4]   Correlation of synovial fluid cytokine levels with histological and clinical parameters of primary and revision total hip and total knee replacements [J].
Clarke, SA ;
Brooks, RA ;
Hobby, JL ;
Wimhurst, JA ;
Myer, BJ ;
Rushton, N .
ACTA ORTHOPAEDICA SCANDINAVICA, 2001, 72 (05) :491-498
[5]  
Frommelt L., 2000, INTERFACES TOTAL HIP, P153
[6]  
Gallo Jiri, 2002, Biomedical Papers (Olomouc), V146, P21
[7]   Efficacy of ex vivo OPG gene therapy in preventing wear debris induced osteolysis [J].
Goater, JJ ;
O'Keefe, RJ ;
Rosier, RN ;
Puzas, JE ;
Schwarz, EM .
JOURNAL OF ORTHOPAEDIC RESEARCH, 2002, 20 (02) :169-173
[8]  
HARRIS WH, 1995, CLIN ORTHOP RELAT R, P46
[9]   Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies normal controls [J].
Haynes, DR ;
Barg, E ;
Crotti, TN ;
Holding, C ;
Weedon, H ;
Atkins, GJ ;
Zannetino, A ;
Ahern, MJ ;
Coleman, M ;
Roberts-Thomson, PJ ;
Kraan, M ;
Tak, PP ;
Smith, MD .
RHEUMATOLOGY, 2003, 42 (01) :123-134
[10]   Osteoprotegerin and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclast formation by cells in the human rheumatoid arthritic joint [J].
Haynes, DR ;
Crotti, TN ;
Loric, M ;
Bain, GI ;
Atkins, GJ ;
Findlay, DM .
RHEUMATOLOGY, 2001, 40 (06) :623-630